Low libido in perimenopause: separating desire, pain and exhaustion

Three problems, one complaint

Almost every consultation about low libido in midlife turns out to be one or more of three distinct things, and they have different treatments.

The first is desire itself — the initiating interest. The second is pain or discomfort, which suppresses desire entirely rationally: nobody seeks out something that hurts. The third is capacity, meaning exhaustion, low mood and having nothing left, which flattens desire in anyone regardless of hormones.

Working out which of the three dominates before an appointment is the single most useful preparation, because a conversation that starts with low libido tends to get a hormonal answer even when the actual problem is pain or sleep.

The desire component

Testosterone contributes to sexual desire in women as well as men, and levels decline gradually from the twenties onwards rather than dropping at menopause. Women who have had their ovaries removed are the exception, losing a substantial share abruptly.

Estrogen's role in desire is less direct than often assumed; its clearer effect is on tissue and comfort. Testosterone supplementation for low sexual desire after menopause has trial support and is recognised in guidance for women with distressing low desire where other causes have been addressed, though availability and licensing vary considerably by country.

Desire also responds to context far more than to any single hormone — relationship quality, stress, body image and self-esteem all carry real weight, and saying so is not a way of dismissing the physiology.

The pain component, which is the most fixable

Genitourinary syndrome of menopause — thinning, drying and reduced elasticity of vulval and vaginal tissue as estrogen falls — affects a large share of postmenopausal women and, unlike hot flashes, does not improve with time. It progresses.

It is also the most treatable symptom in this whole field. Local vaginal estrogen acts on the tissue directly, with minimal systemic absorption, and is considered appropriate for a far wider group than systemic hormone therapy. Non-hormonal moisturisers and lubricants have a genuine role alongside it.

The reason this matters so much here: pain is frequently reported as low libido, then treated as a desire problem, and nothing works. Being specific about discomfort changes the outcome.

The capacity component

Sleep deprivation, depression and the medications used to treat depression all reduce sexual desire substantially. SSRIs in particular are a very common and frequently unmentioned cause of low libido and difficulty reaching orgasm.

If low libido began within weeks of starting an antidepressant, that is worth raising with the prescriber, because alternatives with different profiles exist. This is not a reason to stop a medication that is working.

When to see someone

Any of the three components is worth an appointment when it bothers you — distress, not frequency, is the clinical threshold and it is the one used in guidance.

Be specific about which of the three you have, mention pain explicitly if it is present, and list current medications. If pain is the issue, ask about local vaginal estrogen by name: it is underprescribed relative to how well it works and how favourable its safety profile is.